Table 3 Demographic and clinical characteristics
Midazolam-Ketamine | Midazolam-Propofol | p | ||
|---|---|---|---|---|
Sex | Male (n) | 10 (50%) | 13 (65%) | 0.337 |
Female (n) | 10 (50%) | 7 (35%) | ||
Age (mean ± SD) (years) | 3.1 ± 1.68 | 4.75 ± 3.55 | 0.068 | |
MR procedure time (mean ± SD) (min) | 17.5 ± 11.41 | 13.75 ± 2.75 | 0.161 | |
Total procedure time (mean ± SD) (min) | 22.15 ± 11.66 | 19.5 ± 3.59 | 0.338 | |
Weight (mean ± SD) (kg) | 13.8 ± 4.13 | 17.9 ± 8.38 | 0.057 | |
ASA (n) | I:13 | I:14 | 0.25 | |
II:7 | II:6 | |||
MRI scanning quality (n) | 1:14 (70%) | 1: 9 (45%) | 0.114 | |
2: 6 (30%) | 2:11 (55%) | |||
3:0 | 3:0 | |||
Family Satisfaction (n) | 1:14 (70%) | 1:9 (45%) | 0.114 | |
2:6 (30%) | 2:11 (55%) | |||
3: 0 | 3:0 | |||
RSS (min-max) | 1-5 | 2-4 | 0.826 | |